• Fusion Pharmaceuticals is a clinical stage company focused on developing novel and targeted alpha therapeutics for the treatment of cancer.

    Seroba Contact: Alan O'Connell
    Country: Canada, Ireland


    http://fusionpharma.com/
  • Endotronix is developing an implantable pulmonary artery pressure sensor and integrated patient management platform to provide comprehensive management tools for heart failure patients.

    Seroba Contact: Jennifer McMahon
    Country: USA, Ireland


    http://endotronix.com
  • MedLumics is developing optically-guided, minimally-invasive instruments to improve the treatment of atrial fibrillation and other arrhythmias.

    Seroba Contact: Daniel O'Mahony
    Country: Spain, Ireland


    https://www.medlumics.com/en/
  • Atlantic Therapeutics has developed a CE marked, neuromuscular electrical stimulation device, Innovo™, that treats urinary and faecal incontinence in a non-invasive manner.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, UK, France, Germany


    http://www.atlantictherapeutics.com/
  • Prexton is a clinical stage biotech that is developing novel treatments for the debilitating symptoms of late stage Parkinson’s disease.

    Seroba Contact: Alan O'Connell
    Country: Switzerland, The Netherlands


    http://www.prextontherapeutics.com/
  • Opsona is developing novel antibody therapeutics targeting toll-like immune receptors for the treatment of oncology and inflammatory conditions.

    Seroba Contact: Alan O'Connell
    Country: Ireland


    http://www.opsona.com/
  • Novate Medical has developed a novel inferior vena cava filter that converts from a filter to a stent, providing protection to patients at risk of pulmonary embolism.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, UK


  • Quanta Dialysis Technologies is developing advanced haemodialysis systems for dialysis patients which can be used in the home and in the clinic.

    Seroba Contact: Peter Sandys
    Country: UK


    http://www.quantadt.com/
  • Veryan is developing innovative stent solutions which mimic the vascular system's own flow dynamics in order to treat peripheral vascular disease.

    Seroba Contact: Alan O'Connell
    Country: Ireland, UK


    http://www.veryanmed.com/
  • Apica Cardiovascular has developed novel access and closure devices for structural heart disease. Apica was acquired by Thoratec in 2014.

    Seroba Contact: Daniel O'Mahony
    Country: Ireland, USA


  • Heart Metabolics is developing a drug to treat a rare heart disorder called hypertrophic cardiomyopathy.

    Seroba Contact: Alan O'Connell
    Country: Ireland, USA


    http://www.heartmetabolics.com/
  • PQ Bypass is developing a novel vascular stent graft, ancillary tools and an innovative procedure that treats long lesions in the peripheral vasculature.

    Seroba Contact: Daniel O'Mahony
    Country: USA, Ireland


    http://pqbypass.com/
  • Ario Pharma is developing new therapeutics for the treatment of pain and type II diabetes with pharmaceutical partners.

    Seroba Contact: Alan O'Connell
    Country: UK


    http://www.ariopharma.com/
  • Xention is a cardiovascular biotech company. Its assets have now been partnered with or acquired by pharmaceutical companies.

    Seroba Contact: Alan O'Connell
    Country: UK


    http://www.xention.com/
  • Covagen was a biotech company that developed a novel platform technology for discovery and development of bispecific antibodies. The company was acquired by Janssen.

    Seroba Contact: Daniel O'Mahony
    Country: Switzerland


  • Biosensia is developing the RapiPlex, a point-of-care diagnostic platform which is capable of producing laboratory-quality results in a 10-15 minute timeframe to detect a wide number of diseases.

    Seroba Contact: Jennifer McMahon
    Country: Ireland


    http://www.biosensia.com/
  • Labcyte is developing the revolutionary Echo acoustic liquid handling technology for applications in research and drug development.

    Seroba Contact: Peter Sandys
    Country: USA, Ireland


    http://www.labcyte.com/
  • Alimentary Health has developed microbiome-based healthcare and nutritional products for inflammatory and other conditions.

    Seroba Contact: Peter Sandys
    Country: Ireland


    http://www.alimentaryhealth.ie/
  • Crescent Diagnostics has developed Osentia®, a commercially available diagnostic test to identify an individual's risk of developing osteoporosis.

    Seroba Contact: Alan O'Connell
    Country: UK


    https://www.osentia.co.uk
  • AGI Therapeutics was a specialty pharmaceutical company that was focused on the development and commercialisation of specialty drug products. The company was acquired by Vidara Therapeutics.

    Seroba Contact: Peter Sandys
    Country: Ireland